SCM
HAE icon

Shelton Capital Management’s Haemonetics HAE Stock Holding History

Shelton Capital Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,487
Closed -$223K – 744
2023
Q3 		$223K Hold
2,487
– – 0.01% 606
2023
Q2 		$212K Sell
2,487
-140
-5% -$11.8K 0.01% 675
2023
Q1 		$217K Hold
2,627
– – 0.01% 644
2022
Q4 		$207K Sell
2,627
-187
-7% -$15K 0.02% 637
2022
Q3 		$208K Buy
+2,814
New +$202K 0.01% 620
2021
Q2 		– Sell
-2,814
Closed -$312K – 844
2021
Q1 		$312K Sell
2,814
-139
-5% -$17.2K 0.01% 539
2020
Q4 		$351K Hold
2,953
– – 0.02% 442
2020
Q3 		$258K Hold
2,953
– – 0.01% 590
2020
Q2 		$264K Sell
2,953
-153
-5% -$15.5K 0.01% 488
2020
Q1 		$310K Sell
3,106
-193
-6% -$20.9K 0.02% 386
2019
Q4 		$379K Sell
3,299
-161
-5% -$19.5K 0.02% 441
2019
Q3 		$436K Hold
3,460
– – 0.03% 390
2019
Q2 		$416K Buy
3,460
+3,133
+958% +$308K 0.02% 407
2019
Q1 		$3.74K Sell
327
-3,412
-91% -$310K 0.01% 658
2018
Q4 		$374K Hold
3,739
– – 0.03% 385
2018
Q3 		$428K Sell
3,739
-1,405
-27% -$145K 0.02% 414
2018
Q2 		$461K Hold
5,144
– – 0.03% 376
2018
Q1 		$376K Buy
5,144
+445
+9% +$30.5K 0.02% 453
2017
Q4 		$273K Hold
4,699
– – 0.02% 629
2017
Q3 		$211K Sell
4,699
-467
-9% -$19.4K 0.01% 764
2017
Q2 		$204K Buy
+5,166
New +$212K 0.01% 805

Other funds holding HAE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Shelton Capital Management's HAE Position: Q4 2023 in Review

Shelton Capital Management sold out of Haemonetics (HAE) in Q4 2023, closing a stake of 2,487 shares — an estimated $223K sold.

Shelton Capital Management first reported a position in HAE in Q2 2017 and held it in 21 quarters. The position peaked at $461K in Q2 2018. 295 funds tracked by Wall St. Rank hold HAE as of Q4 2023.

  • Shelton Capital Management reported no remaining Haemonetics position as of Q4 2023 after selling out during the quarter.
  • Shelton Capital Management sold 2,487 Haemonetics shares in Q4 2023, an estimated $223K.
  • Shelton Capital Management first reported a position in Haemonetics in Q2 2017 and held it in 21 quarters.
  • Shelton Capital Management's Haemonetics position peaked at $461K in Q2 2018.
  • 295 funds tracked by Wall St. Rank held Haemonetics as of Q4 2023.

Based on Shelton Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.